Singapore · Series A startup

Who invested in Neuroglee Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$10Mraised across 1 round since 2021, from 1 source

Latest round
Series A, $10MSept 2021
Investors
3
See who backed them

The rounds

  1. Sept 2021
    Series A$10M

    Source recorded

Everyone who backed them

EDBIVC firm1round
IsaiVC firm1round
Space CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Neuroglee Therapeutics

Who invested in Neuroglee Therapeutics?

Neuroglee Therapeutics's investors include EDBI, Isai and Space Capital.

How much has Neuroglee Therapeutics raised?

Neuroglee Therapeutics has raised $10M across 1 round since 2021.

When did Neuroglee Therapeutics last raise?

Neuroglee Therapeutics's most recent round was a Series A of $10M in Sept 2021.

What was Neuroglee Therapeutics's biggest round?

Its most recent round, $10M in Sept 2021, is also its largest on record.

Who backed Neuroglee Therapeutics first?

Neuroglee Therapeutics's first round on record, in Sept 2021, was backed by EDBI, Isai and Space Capital.

What stage is Neuroglee Therapeutics at?

Neuroglee Therapeutics's latest named round is a Series A, in Sept 2021.

Where is Neuroglee Therapeutics based?

Neuroglee Therapeutics is based in Singapore.

Companies like Neuroglee Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.